Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
Clinical trial NCT07484022 · RECRUITING
Trial details
- NCT number
- NCT07484022
- Sponsor
- Generate Biomedicines
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-06-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.